Buprenorphine was associated with a 50% reduction in mortality and improved treatment retention for adolescents with opioid use disorder.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results